Patricia Penovich
Neurology · Saint Paul, MNNPI 1548287436
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Neurelis, Inc. at 57.5% of the total. Reporting peaked in 2022 at $75,950 and has fallen 59.1% since, to $31,038 in 2025. Among neurology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 305 payments — averaging $997.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$175K
- Greenwich Biosciences, Inc.$38K
- SK Life Science, Inc.$37K
- UCB, Inc.$24K
- Jazz Pharmaceuticals Inc.$19K
- Aquestive Therapeutics, Inc.$6K
- plus $6K from 2 others
Across 3 payments — averaging $3404.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB, Inc.$8K
- Eisai Inc.$2K
What the payments were for
- Consulting fees$166,35155%
- Speaking & faculty fees$107,92835%
- Travel & lodging$23,2398%
- Food & beverage$6,7862%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 169 | $175,055 |
| Greenwich Biosciences, Inc. | 34 | $37,811 |
| SK Life Science, Inc. | 36 | $36,870 |
| UCB, Inc. | 35 | $23,870 |
| Jazz Pharmaceuticals Inc. | 17 | $18,731 |
| Aquestive Therapeutics, Inc. | 11 | $6,168 |
| UCB SA | 2 | $5,400 |
| Monteris Medical Corporation | 1 | $400 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VALTOCO$173,191
- Epidiolex$55,921
- XCOPRI$18,270
- Cenobamate$15,563
- Nayzilam$9,839
- SYMPAZAN$5,903
- Vimpat$3,751
- Briviact$1,500
- Neuroblate$400
How this compares
$304,304 in reported general payments places this provider in the 95th percentile of 434 neurology providers in Minnesota.
Other neurology in Saint Paul
- Ryan LeeSaint Paul$50K
- Gaurav GulianiSaint Paul$22K
- Jeffery AllenMinneapolis$1.1M
- Jonathan CalkwoodGolden Valley$493K
- Alejandro RabinsteinRochester$305K
- Sean PittockRochester$231K
- Irfan AltafullahGolden Valley$203K
- Jessica StulcGolden Valley$199K
- Akram DastagirGolden Valley$174K
- Jessica HeiringGolden Valley$149K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.